FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

83 letters match. Newest first.

  1. Deggeh Foods, Inc.

    FDA says Deggeh Foods sold supplement capsules and Moringa tea as unapproved drugs and violated manufacturing rules.

    High risk
  2. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  3. CAJ Food Products Inc.

    CAJ Food Products marketed Biotta and Juice Performer juices with disease claims, making them unapproved new drugs, FDA says.

    High risk
  4. Ayuryoga, Inc.

    FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.

    High risk
  5. MYA International, Inc.

    FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.

    High risk
  6. Crystal Clear Supplements

    Crystal Clear Supplements took orders for tianeptine and other products FDA calls unapproved new drugs.

    High risk
  7. Glenn Burkett Naples Corporation

    Glenn Burkett Naples Corporation sold colloidal silver and supplement products as unapproved drugs, including claims to treat COVID-19.

    High risk
  8. GeroNova Research Inc.

    FDA warned GeroNova Research that disease claims on its Amazon store and social media make its carnitine and R-lipoic acid supplements unapproved, misbranded drugs.

    Medium
  9. Medtronic, Inc.

    FDA warns Medtronic over inadequate CAPA and complaint handling for MiniMed insulin pumps linked to retainer-ring failures and cybersecurity risks.

    High risk
  10. New Green Nutrition, Inc.

    FDA warned New Green Nutrition that its diabetes products were unapproved new drugs and one contained prescription glyburide sold without a prescription.

    High risk
  11. ICA Health, LLC/Future Formulations, LLC

    ICA Health sells five Dr. Wilson supplements with website claims that make them unapproved new drugs, FDA says.

    Medium
  12. Supplement Science Corp. d/b/a Condemned Labz

    FDA warned Condemned Labz that five supplement products were unapproved new drugs and misbranded, and two were adulterated.

    High risk
  13. Brilliant Enterprises LLC

    FDA warned Brilliant Enterprises that its mushroom products are unapproved new drugs because website and social media claims say they treat diseases.

    Medium
  14. Pharmaganics LLC

    FDA and FTC warn Pharmaganics over diabetes supplement claims that make unapproved, misbranded drugs.

    High risk
  15. Phytag Labs

    FDA and FTC warn Phytag Labs that its GLUCOTYPE2 supplement is an unapproved drug and misbranded due to diabetes treatment claims.

    Medium
  16. Nuturna International LLC

    Nuturna International marketed 'Diabetic Support Formula' with diabetes-treatment claims, making it an unapproved drug and misbranded.

    High risk
  17. Metamune Inc

    FDA and FTC warn Metamune over DiabetesSupport supplement claims to treat diabetes without approval.

    High risk
  18. Live Good Inc.

    Live Good Inc. sold Berry Gen Sugar Control supplements as a diabetes treatment without FDA approval, making it an unapproved, misbranded drug.

    High risk
  19. Radhanite, LLC d/b/a Curalife Ltd

    FDA and FTC say Curalife markets CuraLin supplement with unapproved diabetes-treatment claims.

    High risk
  20. Aceva, LLC

    Aceva, LLC marketed Sugar Balance supplement with unapproved diabetes and blood sugar drug claims, FDA says.

    High risk
  21. Ar-Rahman Pharm LLC

    FDA and FTC cite Ar-Rahman Pharm for Diabetes Support sold with unapproved diabetes-treatment claims.

    High risk
  22. Lysulin, Inc.

    Lysulin, Inc. marketed diabetes and weight-loss supplements as unapproved drugs and misbranded products.

    High risk
  23. Holistic Healer & Wellness Center, Inc.

    FDA and FTC warned Holistic Healer & Wellness Center that Diabalance Diabetes Supplement claims make it an unapproved new drug.

    High risk
  24. TeaTaze, LLC

    TeaTaze marketed eight teas with claims they treat diseases, including COVID-19, making them unapproved new drugs, FDA says.

    High risk
  25. Nutrishus Brands, Inc.

    FDA warned Nutrishus Brands that its RxSugar sweeteners were unapproved new drugs and misbranded foods due to website disease and health claims.

    Low
  26. Phoenix Nutritionals, Inc.

    FDA warned Phoenix Nutritionals that disease-treatment claims on its supplement websites make eight products unapproved drugs, including COVID-19 claims.

    High risk
  27. JLM Nutritionals, Inc. dba JLM Nutrition—Super Naturals Health

    FDA says JLM Nutritionals marketed five Super Naturals supplements as unapproved drugs with disease claims on websites, Amazon, and Facebook.

    High risk
  28. DRF LLC

    FDA warned DRF LLC that Boston C, Mega-Dose Vitamin C, and Pixie Dust Magnesium were unapproved drugs promoted for treating cancer.

    High risk
  29. Omega Wonders LLC.

    Omega Wonders LLC sells Cardia 7 and Tear Health supplements with disease claims, making them unapproved new drugs and misbranded.

    Low
  30. EU Natural Inc.

    EU Natural's fertility supplements are unapproved new drugs because website claims treat infertility, PCOS, cancer and other diseases.

    High risk
  31. Immune & Genetics Protocols, LLC

    FDA warned Immune & Genetics Protocols that website claims its Immune Bio Green Cell treats cancer, diabetes and HIV make it an unapproved new drug.

    High risk
  32. Orphic Nutrition

    FDA warned Orphic Nutrition that its supplement capsules and gummies are unapproved new drugs because website claims say they treat diseases.

    High risk
  33. Duoc Thao Tre Xanh, LLC

    FDA warned Duoc Thao Tre Xanh that its four herbal products are unapproved new drugs based on website disease claims.

    High risk